Résumé
Pseudomonas aeruginosa is an opportunistic pathogen that is a common cause of nosocomial infections. The molecular mechanisms governing immune responses to P. aeruginosa infection remain incompletely defined. Early growth response 1 (Egr-1) is a zinc-finger transcription factor that controls inflammatory responses. Here, we characterized the role of Egr-1 in host defense against P. aeruginosa infection in a mouse model of acute bacterial pneumonia. Egr-1 expression was rapidly and transiently induced in response to P. aeruginosa infection. Egr-1-deficient mice displayed decreased mortality, reduced levels of proinflammatory cytokines (tumor necrosis factor [TNF], interleukin-1β [IL-1β], IL-6, IL-12, and IL-17), and enhanced bacterial clearance from the lung. Egr-1 deficiency caused diminished NF-κB activation in P. aeruginosa-infected macrophages independently of IκBα phosphorylation. A physical interaction between Egr-1 and NF-κB p65 was found in P. aeruginosainfected macrophages, suggesting that Egr-1 could be required for assembly of heterodimeric transcription factors that direct synthesis of inflammatory mediators. Interestingly, Egr-1 deficiency had no impact on neutrophil recruitment in vivo due to its differential effects on chemokine production, which included diminished accumulation of KC (CXCL1), MIP2 (CXCL2), and IP-10 (CXCL10) and increased accumulation of LIX (CXCL5). Importantly, Egr-1-deficient macrophages and neutrophils displayed significant increases in nitric oxide production and bacterial killing ability that correlated with enhanced bacterial clearance in Egr-1-deficient mice. Together, these findings suggest that Egr-1 plays a detrimental role in host defense against P. aeruginosa acute lung infection by promoting systemic inflammation and negatively regulating the nitric oxide production that normally assists with bacterial clearance.
Langue d'origine | English |
---|---|
Numéro d'article | e00678-19 |
Journal | Infection and Immunity |
Volume | 88 |
Numéro de publication | 1 |
DOI | |
Statut de publication | Published - janv. 1 2020 |
Note bibliographique
Funding Information:This work was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) grant no. RGPIN-05446, Canadian Institutes of Health Research (CIHR) grant no. MOP-68815, a Cystic Fibrosis Canada Marsha Morton Early Career Investigator award, and a grant from the Canada Foundation for Innovation John R. Evans Leaders Fund. We declare that we have no conflict of interest.
Publisher Copyright:
Copyright © 2019 Pang et al.
ASJC Scopus Subject Areas
- Parasitology
- Microbiology
- Immunology
- Infectious Diseases